The UK Government has granted £86m to small and medium-sized enterprises (SMEs) for the development and testing of new healthcare technologies in the National Health Service (NHS).

Aimed at accelerating access to medicine and technology, the funding is split into four packages to support both digital healthcare and new drugs.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Of the total grant, £39m will be used by the Academic Health Science Networks (ASHNs) to evaluate the uses of new technologies and also support NHS uptake of the technologies that provide benefits with respect to local need.

A £35m Digital Health Technology Catalyst is granted for the development of digital technologies that can be used by the NHS as well as by the patients to manage their conditions from home.

Furthermore, a £6m Pathway Transformation Fund is provided for integration of new technologies by the NHS into everyday practices, and an additional £6m will be offered over the coming three years to investigate new medicines and devices in the real world.

See Also:

"The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible."

Health Minister Lord O’Shaughnessy said: “The government’s ambition is that NHS patients get world-leading, life-changing treatments as fast as possible.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“That can’t happen unless we support medical innovation and tear down the barriers – like speed to market and access to funding – that can get in the way, especially for SMEs.

“Our investment in innovation shows how much we value the UK life sciences sector.”

The government has also previously funded several technologies, which are reported to be currently in use and beneficial to patients.